Efficacy and Tolerability of a Fixed Combination of Perindopril/Amlodipine/Indapamide in Patients with Essential Hypertension: Pilot Study / Efikasnost I Tolerabilnost Fiksne Kombinacije Perindopril/Amlodipin/Indapimida Kod Pacijenata Sa Esencijalnom Hipertenzijom: Pilot Studija

1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003 May 14; 289(18): 2363-9.10.1001/jama.289.18.236312746359Search in Google Scholar

2. Wolf-Maier K, Cooper R, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10-17.10.1161/01.HYP.0000103630.72812.1014638619Search in Google Scholar

3. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal doi:10.1093/ eurheartj/eht151 published June 14, 2013.Search in Google Scholar

4. Bramlage P, Böhm M, Volpe M, Khan BV, Paar DW, Tebbe U and Thoenes M. A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients. J Clin Hypertens 2010. 12(9): 666-677.10.1111/j.1751-7176.2010.00322.x867311220883226Search in Google Scholar

5. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55(2):399-407.10.1161/HYPERTENSIONAHA.109.13981620026768Search in Google Scholar

6. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4(6):393-404.10.1111/j.1524-6175.2002.02045.x12461301Search in Google Scholar

7. Jamerson K, Weber MA, Bakris GL, DahlofB, Pitt B, ShiV, HesterA, Gupte J, Gatlin M, Velazquez EJ. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. 2008. N engl J med 359; 23.10.1056/NEJMoa080618219052124Search in Google Scholar

8. Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Press. 2001;10:62-73.10.1080/0803705015211204111467762Search in Google Scholar

9. Ruzicka M, Leenen FH. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension. Drugs. 2001;61:943-954.10.2165/00003495-200161070-0000411434450Search in Google Scholar

10. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560-2572.10.1001/jama.289.19.256012748199Search in Google Scholar

11. Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med. 1996;156:1969-1978.10.1001/archinte.1996.00440160081011Search in Google Scholar

12. Gradman AH, Basile JN, Carter BL, Bakris GL; American Society of Hypertension Writing Group. Combination therapy in hypertension. J Clin Hypertens (Greenwich). 2011;13:146-154.10.1111/j.1751-7176.2010.00397.xSearch in Google Scholar

13. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290-300.10.1016/j.amjmed.2008.09.038Search in Google Scholar

14. Bangalore S, Kamalakkannan G, Parkar S, at al. Fixed- Dose Combinations Improve Medication Compliance: meta-analysis on 11,925 participants from 9 trials, Am J Med (2007) 120, 713-719.10.1016/j.amjmed.2006.08.033Search in Google Scholar

15. Calhoun DA, Lacourciere Y, Chiang YT, Glazer RD. Triple antihypertensive therapy with Amlodipine, Valsartan, and Hydrochlorothiazide. A randomized clinical trial. Hypertension. 2009;54(1):32-39. 10.1161/HYPERTENSIONAHA.109.131300Search in Google Scholar

16. Oparil S, Melino M, Lee J, Fernandez V, Heyrman R. Triple therapy with Olmesartan medoxomil, Amlodipine besylate, and Hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. Clin Ther. 2010;32(7):1252-69.10.1016/j.clinthera.2010.07.008Search in Google Scholar

17. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial- Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366 (9489):895-906.10.1016/S0140-6736(05)67185-1Search in Google Scholar

18. Jadhav U, Hiremath J,, Namjoshi DJ, Gujral VK, Tripathi KK, Siraj M, Shamanna P, Safar8 M. Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained- Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study. PLos one. 2014. 9(4): e92955.10.1371/journal.pone.0092955397964824714044Search in Google Scholar

19. Kalman T. Antihypertensive Efficacy of Triple Combination Perindopril/ Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus Amlodipine in high risk hypertensive patients): original research article. Am J Cardiovasc Drugs. 2014. Search in Google Scholar